Is snus harmful? This question concerns consumers, health authorities and scientists alike. The answer is more nuanced than the polarised debate suggests. While cigarette smoke releases more than 7,000 chemical compounds (including at least 70 proven carcinogens), snus does away with combustion entirely. At Heimat we go one step further: our Nicotine Pouches are completely tobacco-free and therefore contain no tobacco-specific nitrosamines (TSNA) either. In this article we look at the current research on snus side effects, cancer risk, cardiovascular effects and addiction potential, and show where tobacco-free pouches sit on the risk spectrum. All statements are based on peer-reviewed studies and epidemiological data from Sweden, the country with the longest snus tradition and the best data.
Snus and cancer risk: what do the studies say?
When it comes to how harmful snus is, the most debated question is probably cancer risk. First, one crucial distinction: Swedish snus is pasteurised, not fermented. This heat treatment lowers the content of tobacco-specific nitrosamines (TSNA), the potentially carcinogenic substances in tobacco, by a factor of 5 to 100 compared with fermented oral tobacco products such as American chewing tobacco or South Asian gutkha (Österdahl et al., 2004).
Meta-analyses and large studies
A comprehensive meta-analysis by Lee & Hamling (2009), pooling data from more than 80 studies, reached a remarkable conclusion: Swedish snus shows no statistically significant increase in risk for oral cancer, lung cancer or stomach cancer. The authors stress how important it is to distinguish between pasteurised Swedish snus and other forms of oral tobacco.
In a long-term study of more than 400,000 male Swedish construction workers, Sweden's Karolinska Institute examined the link between snus use and various types of cancer (Luo et al., 2007). The results in detail:
| Type of cancer | Relative risk (snus vs. non-users) | Statistically significant? |
|---|---|---|
| Oral cancer | 0.9 (95% CI: 0.7–1.2) | No |
| Lung cancer | 0.8 (95% CI: 0.6–1.1) | No |
| Pancreatic cancer | 1.2 (95% CI: 0.9–1.6) | No |
| Stomach cancer | 1.0 (95% CI: 0.7–1.3) | No |
| Oesophageal cancer | 1.1 (95% CI: 0.7–1.7) | No |
Each confidence interval (CI) includes the value 1.0. This means no statistically increased risk could be demonstrated. In this cohort, the overall cancer risk among snus users was not significantly higher than among non-users.
TSNA levels compared
A look at TSNA concentrations shows why Swedish snus performs comparatively well when it comes to cancer:
| Product type | TSNA content (ng/g) | Production method |
|---|---|---|
| Swedish snus (modern) | 500–3.000 | Pasteurisation (heating) |
| American chewing tobacco | 20.000–100.000 | Fermentation |
| South Asian gutkha | 50.000–200.000+ | Fermentation, additives |
| Nicotine pouches (tobacco-free) | Not detectable | Synthetic/extracted nicotine |
Since the 1980s, the Swedish food authority has systematically lowered TSNA levels in snus products. Manufacturers such as Swedish Match follow the GOTHIATEK standard, which sets limits for potentially harmful substances that are stricter than any legal requirement.
Important caveat: The International Agency for Research on Cancer (IARC) classifies smokeless tobacco as a whole as carcinogenic, without distinguishing between product types. The results above refer to Swedish, pasteurised snus. Other forms of oral tobacco have a clearly different risk profile.
Tobacco-free nicotine pouches: a different risk profile
The table above shows that tobacco-free Nicotine Pouches contain no detectable TSNA. This removes the risk factor that remains in reduced form in tobacco snus, despite pasteurisation. At Heimat we deliberately chose to make tobacco-free pouches because we believe this difference matters.
The risk profile of tobacco-free pouches differs from tobacco snus in several ways:
- No TSNA exposure: since no tobacco is processed, no tobacco-specific nitrosamines are formed, neither through fermentation nor as residue after pasteurisation
- Lower potential for mucosal changes: early research suggests that tobacco-free pouches cause fewer reactions of the oral mucosa than tobacco snus
- No tooth staining: without tobacco, there are none of the pigments that cause staining with classic snus
- Nicotine dependence remains: the active substance nicotine is identical, so the addiction potential is comparable to tobacco snus
Our commitment to a science-based approach is also reflected in the make-up of our advisory board: with Prof. Dr. med. Felix Niggli, a renowned oncologist, we have an expert on board who accompanies our product development from a medical perspective. For us this sends a clear signal: we take health questions seriously and rely on scientific evidence rather than marketing promises.
Note: Tobacco-free pouches have only been on the market for a few years. Long-term studies covering 20+ years, like those available for Swedish tobacco snus, do not exist yet. Findings so far are, however, consistent with a lower potential for harm compared with tobacco products. If you are looking for classic tobacco snus from international brands, you will find it there.
Oral health and gums: the most common changes
The most direct contact is between the snus pouch and the oral mucosa. This is where the best-documented snus side effects of long-term use appear.
Mucosal changes (lesions)
Visible changes to the oral mucosa can appear where the snus pouch is regularly placed. The research group of Roosaar et al. (2006) studied these lesions in a long-term study over several years and documented:
- Frequency: in regular users, visible mucosal changes develop at the preferred placement site in more than 50% of cases
- Reversibility: the changes usually disappear completely within weeks to months after stopping
- Malignant potential: the rate of malignant transformation of these lesions was not increased in the study. This is a key difference from lesions caused by fermented oral tobacco in South Asia
Gum recession (gingival recession)
Local gum recession at the placement site is one of the most frequently reported long-term effects. A Swedish study by Hugoson & Rolandsson (2011) quantified the extent:
| Usage pattern | Average recession | Teeth affected |
|---|---|---|
| Occasional (1–3 cans/week) | 0.5–1.0 mm | 1–2 teeth |
| Regular (1 can/day) | 1.0–2.0 mm | 2–4 teeth |
| Heavy use (2+ cans/day) | 2.0–3.5 mm | 3–6 teeth |
By comparison, periodontitis caused by smoking typically affects the whole mouth and is associated with irreversible bone loss. Snus-related gum recession stays localised and can be minimised by regularly changing the placement site.
Tooth staining and caries
Loose snus in particular can stain teeth. Portion snus, especially white varieties, causes much less staining. When it comes to caries, the data paint an unexpected picture: several studies found no increased caries rate among snus users. The alkaline pH of snus (typically 8.0–8.5) might even have a slight protective effect, as caries bacteria prefer an acidic environment.
Our Heimat Nicotine Pouches are tobacco-free and, in early research, show a lower potential for mucosal changes. Tooth staining is not an issue at all, as they contain no tobacco. Long-term data are still limited here, since tobacco-free pouches have only been on the market for a few years. If you prefer classic tobacco snus, you will find a wide range of international brands at snus-shop.com.
Cardiovascular system: a nuanced picture
Nicotine affects the cardiovascular system, whatever the form of use. In the short term it raises heart rate and blood pressure by stimulating the sympathetic nervous system. The key question is: does this lead to more heart attacks, strokes or other cardiovascular events among snus users in the long run?
Acute effects of snus on the heart and circulation
Right after a snus pouch is put in, the body reacts measurably:
| Parameter | Change with snus | Comparison: cigarette |
|---|---|---|
| Heart rate | +5–10 bpm | +10–20 bpm |
| Systolic blood pressure | +5–10 mmHg | +10–20 mmHg |
| Adrenaline release | Moderate | High |
| Carbon monoxide in the blood | No increase | Sharply increased |
| Vasoconstriction | Mild, short-term | Pronounced, intensified by CO |
The decisive difference: when you smoke, it is not only nicotine that acts on the blood vessels, but also carbon monoxide (CO), fine particles, hydrogen cyanide and oxidative stress from free radicals. These factors are completely absent with snus.
Long-term risks: what cohort studies show
Research on long-term cardiovascular effects paints a nuanced picture:
- Heart attack (myocardial infarction): a Swedish cohort study of more than 118,000 construction workers found no increased risk of a first heart attack among snus users (Hergens et al., 2007). The relative risk was 0.91 (95% CI: 0.81–1.02).
- Stroke: the data are contradictory. Hergens et al. (2008) found a slightly increased risk of fatal stroke (RR 1.27; 95% CI: 0.92–1.76), which was not statistically significant, however. Other studies could not confirm this link.
- High blood pressure: snus does not appear to cause lasting hypertension. Acute rises in blood pressure return to normal within 15–30 minutes after the pouch is removed (Bolinder et al., 1992).
- After a heart attack: continuing to use snus after a heart attack appears to worsen the prognosis. Arefalk et al. (2014) showed an increased risk of heart failure in patients who kept using snus after an infarction.
In short: snus is not risk-free for the cardiovascular system, but the overall cardiovascular risk is clearly lower than with smoking, mainly because there are none of the combustion products that cause most smoking-related vascular damage.
Snus and pregnancy
Particularly strict precautions apply to pregnant women. Whatever the form it is taken in, nicotine narrows the blood vessels of the placenta and reduces the oxygen supply to the foetus. Studies from the Swedish birth register show:
- Snus use during pregnancy is associated with an increased risk of premature birth (Wikstrom et al., 2010)
- Birth weight may be slightly reduced, though less markedly than with smoking
- The risk of pre-eclampsia appears to be higher among women who use snus
The recommendation is clear: avoid all nicotine products during pregnancy and breastfeeding, snus, cigarettes and nicotine pouches alike.
Snus side effects at a glance
Beginners in particular experience various snus side effects, which depend on the dose and are usually temporary:
| Side effect | Frequency | Typical duration | What to do |
|---|---|---|---|
| Nausea | Very common on first use | 15–60 minutes | Remove the pouch, choose a lower strength |
| Dizziness | Common if the dose is too high | 5–30 minutes | Remove the pouch, get some fresh air |
| Burning under the lip | Common | Fades as you get used to it (days) | Change position, choose milder flavours |
| Increased salivation | Common | Fades as you get used to it | Prefer white varieties |
| Hiccups | Occasional | Temporary (minutes) | Reposition the pouch slightly |
| Headache | Occasional | 30–120 minutes | Lower nicotine strength |
| Heartburn | Rare | Temporary | Swallow less saliva |
These side effects mainly occur when the chosen nicotine strength is too high. Beginners are therefore advised to start with low-dose products (2–6 mg/g). Read more in our article What is snus? The complete guide.
Snus and addiction: nicotine is still nicotine
Snus contains nicotine, and nicotine is addictive. This is undisputed and should not be played down. The question is how the dependence compares with smoking.
Addiction potential compared
Fagerstrom & Eissenberg (2012) studied the addiction potential of different nicotine products and found relevant differences:
| Factor | Cigarette | Snus | Nicotine pouches |
|---|---|---|---|
| Speed of nicotine uptake | Very fast (10–20 sec.) | Slow (1–2 min.) | Slow (1–3 min.) |
| Dopamine peak in the brain | Steep, high | Flatter, more even | Flatter, more even |
| Withdrawal symptoms when abstaining | Very pronounced | Moderate | Moderate |
| Average units per day | 15–20 cigarettes | 8–12 pouches | 8–15 pouches |
| Success rate when quitting (unaided) | 3–5 % | Higher than with cigarettes | Limited data |
The rapid nicotine peak when smoking (nicotine reaches the brain within 10–20 seconds) is a key factor in the high addictive potential of cigarettes. With snus, nicotine enters the blood more slowly. This flatter profile tends to go hand in hand with milder dependence (Benowitz, 2010). You can find out more about how nicotine acts in the body in our article How much nicotine is in a cigarette?
Snus as a way to quit smoking?
In Sweden, many former smokers use snus to quit smoking. Epidemiological data show that snus played a significant role there in reducing smoking prevalence (Ramström & Foulds, 2006). Whether snus should be officially recommended as a cessation aid, however, is disputed among health authorities. Swiss health policy takes a pragmatic approach: snus is legal but is not actively promoted as a cessation aid.
The Swedish paradox: facts and figures
Sweden offers a unique natural experiment that is central to the question of how harmful snus is. The country has the highest rate of snus use in the world and, at the same time, the lowest rates of tobacco-related disease in Europe. The figures:
| Indicator | Sweden | EU average | Switzerland |
|---|---|---|---|
| Smoking prevalence, men | 5,6 % | 26 % | 22 % |
| Snus/nicotine pouch users, men | ~19 % | <1% | Growing (~3–5%) |
| Lung cancer rate, men (per 100,000) | 22 | 52 | 39 |
| Tobacco-related mortality, men (per 100,000) | ~150 | ~380 | ~270 |
| Oral cancer rate, men (per 100,000) | 4,2 | 6,1 | 5,3 |
Ramström & Wikmans (2014) analysed tobacco-related mortality in 18 European countries and concluded that if all the countries studied had the Swedish pattern of use (little smoking, more snus), an estimated 200,000 premature deaths a year could have been avoided in Europe.
Critics urge caution with this interpretation. Sweden's low smoking rate could also have other causes: early anti-smoking campaigns, high cigarette prices, cultural factors. Correlation is not causation. Even so, the Swedish example is the strongest real-world argument for the concept of tobacco harm reduction.
How harmful is snus by comparison? Putting it in context
In 2016, the Royal College of Physicians in London, one of the most respected medical institutions in the world, published a comprehensive report on tobacco harm reduction. Its assessment is shared by several health authorities:
| Product | Relative risk of harm (scale) | Main risk factors |
|---|---|---|
| Cigarette | 100 (reference value) | Combustion, tar, CO, TSNA, fine particles |
| Cigar/pipe | 40–60 | Combustion (less inhalation) |
| Snus (Swedish) | 5–10 | TSNA (reduced), nicotine |
| E-cigarette | 5–10 | Aerosol, flavourings, nicotine |
| Nicotine pouches (tobacco-free) | 2–5 | Nicotine, flavourings |
| Nicotine replacement therapy (patch, gum) | 1–2 | Nicotine (pharmaceutical grade) |
So snus is not harmless, but its potential for harm is a fraction of what cigarette smoking causes. Our Heimat Nicotine Pouches belong to the category "nicotine pouches (tobacco-free)", the range with the lowest potential for harm among nicotine-containing products. Swiss Made, produced in Steinach on Lake Constance.
Conclusion: a nuanced picture
The scientific evidence suggests that snus is not risk-free, but clearly less harmful than smoking cigarettes. The main risks concern oral health (local gum recession, mucosal changes) and nicotine dependence. For serious diseases such as cancer or heart attack, the data, at least for Swedish pasteurised snus, show no clearly increased risk.
That is why we at Heimat rely on tobacco-free nicotine pouches: they rule out TSNA exposure completely and offer a more favourable risk profile than tobacco snus. Research is an ongoing process, and new long-term studies will bring more clarity in the coming years. As with any indulgence, what matters most is an informed, self-responsible decision.
Further reading:
Frequently asked questions
Does snus cause cancer? ▾
What are the side effects of snus? ▾
Is snus more harmful than smoking? ▾
Is snus addictive? ▾
Is snus bad for your teeth? ▾
Can you use snus during pregnancy? ▾
What is the Swedish snus paradox? ▾
Are nicotine pouches less harmful than snus? ▾
Sources
- Arefalk, G., et al. (2014). Smokeless tobacco and risk of heart failure. Circulation: Heart Failure, 7(6), 995–1002.
- Benowitz, N. L. (2010). Nicotine addiction. New England Journal of Medicine, 362(24), 2295–2303.
- Bolinder, G., et al. (1992). Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. American Journal of Public Health, 84(3), 399–404.
- Fagerstrom, K., & Eissenberg, T. (2012). Dependence on tobacco and nicotine products. Annual Review of Clinical Psychology, 8, 249–268.
- Hergens, M. P., et al. (2007). Long-term use of Swedish moist snuff and the risk of myocardial infarction. Epidemiology, 18(5), 668–673.
- Hergens, M. P., et al. (2008). Smokeless tobacco and the risk of stroke. Epidemiology, 19(6), 794–799.
- Hugoson, A., & Rolandsson, M. (2011). Periodontal disease in relation to smoking and the use of Swedish snus. European Journal of Oral Sciences, 119(5), 370–376.
- Lee, P. N., & Hamling, J. (2009). Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Medicine, 7(1), 36.
- Luo, J., et al. (2007). Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas. The Lancet, 369(9578), 2015–2020.
- Österdahl, B. G., Jansson, C., & Paccou, A. (2004). Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market. Journal of Agricultural and Food Chemistry, 52(16), 5085–5088.
- Ramström, L., & Foulds, J. (2006). Role of snus in initiation and cessation of tobacco smoking in Sweden. Tobacco Control, 15(3), 210–214.
- Ramström, L., & Wikmans, T. (2014). Mortality attributable to tobacco among men in Sweden and other European countries. Tobacco Control, 23(e2), e151–e155.
- Roosaar, A., et al. (2006). A long-term follow-up study on the natural course of snus-induced lesions among Swedish snus users. International Journal of Cancer, 119(2), 392–397.
- Royal College of Physicians. (2016). Nicotine without smoke: Tobacco harm reduction. London: RCP.
- Wikstrom, A. K., et al. (2010). Snuff during pregnancy and risk of pre-eclampsia. BJOG, 117(8), 1005–1010.